Prospera Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Sell |
|
|||||
|
2025
Q1 | $363K | Buy |
|
|||||
|
2024
Q4 | $514K | Sell |
|
|||||
|
2024
Q3 | $751K | Sell |
|
|||||
|
2024
Q2 | $904K | Sell |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $490K | Sell |
|
|||||
|
2023
Q3 | $489K | Sell |
|
|||||
|
2023
Q2 | $367K | Sell |
|
|||||
|
2023
Q1 | $848K | Buy |
|
|||||
|
2022
Q4 | $451K | Sell |
|
|||||
|
2022
Q3 | $499K | Buy |
|
|||||
|
2022
Q2 | $260K | Sell |
|
|||||
|
2022
Q1 | $414K | Buy |
|
|||||
|
2021
Q4 | $218K | Sell |
|
|||||
|
2021
Q3 | $552K | Sell |
|
|||||
|
2021
Q2 | $612K | Sell |
|
|||||
|
2021
Q1 | $739K | Buy |
|
|||||
|
2020
Q4 | $422K | Buy |
|
|||||
|
2020
Q3 | $12K | Sell |
|
|||||
|
2020
Q2 | $548K | Buy |
|
|||||
|
2020
Q1 | $380K | Sell |
|
|||||
|
2019
Q4 | $593K | Buy |
|
|||||
|
2019
Q3 | $281K | Buy |
|
|||||
|
2019
Q2 | $333K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $541K | Buy |
|
|||||
|
2018
Q3 | $535K | Buy |
|
|||||
|
2018
Q2 | $385K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $245K | Sell |
|
|||||
|
2016
Q4 | $286K | Buy |
|